A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

NCT07306182 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Anterior Myocardial Infarction

Interventions

DRUG: SGC001
DRUG: Placebo

Sponsor

Beijing Sungen Biomedical Technology Co., Ltd